Executive/Major Shareholder Securities Report Filed (No Changes)


  • Report filed as per periodic obligation on securities holdings of executives and major shareholders
  • No specific changes, acquisitions, disposals, or quantity variations disclosed
  • The security is listed as DR on KOSDAQ; 1 original share equals 5 DR (all quantities are DR-based)

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: NeoImmuneTech (950220)
  • Submission: Taekyung Kim
  • Receipt: 05-14-2026